CDIO - Cardio Diagnostics Holdings, Inc.
1.82
0 0%
Share volume: 30,670
Last Updated: 04-24-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.82
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-15-2024 | 08-12-2024 | 11-13-2024 | 03-20-2025 | 05-15-2025 | 11-12-2025 | 03-13-2026 | |
| Assets | ||||||||
| Total Assets | 4.328 M | 3.997 M | 4.481 M | 10.615 M | 12.282 M | 8.789 M | 7.766 M | |
| Current Assets | 2.589 M | 2.139 M | 2.627 M | 8.791 M | 10.535 M | 6.927 M | 5.921 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.563 M | 1.310 M | 1.983 M | 7.827 M | 9.689 M | 6.355 M | 5.111 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 588.271 K | 720.175 K | 706.659 K | 672.861 K | 640.992 K | 744.335 K | 700.115 K | |
| Other Assets | 1.150 M | 1.138 M | 1.148 M | 1.152 M | 1.106 M | 1.117 M | 1.146 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 4.328 M | 3.997 M | 4.481 M | 10.615 M | 12.282 M | 8.789 M | 7.766 M | |
| Total liabilities | 1.291 M | 922.529 K | 795.276 K | 1.058 M | 904.998 K | 637.331 K | 793.061 K | |
| Total current liabilities | 685.672 K | 376.096 K | 308.679 K | 631.695 K | 540.616 K | 398.448 K | 604.839 K | |
| Accounts Payable | 224.719 K | 52.081 K | 74.808 K | 87.661 K | 108.181 K | 150.734 K | 97.442 K | |
| Other liabilities | 605.090 K | 546.433 K | 0.000 | 425.829 K | 364.382 K | 238.883 K | 188.222 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 605.090 K | 546.433 K | 0.000 | 425.829 K | 364.382 K | 238.883 K | 188.222 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.037 M | 3.074 M | 3.686 M | 9.558 M | 11.377 M | 8.152 M | 6.973 M | |
| Common stock | 21.569 M | 22.894 M | 24.919 M | 32.310 M | 35.764 M | 35.936 M | 36.223 M | |
| Retained earnings | -18.532 M | -19.820 M | -21.233 M | -22.752 M | -24.387 M | -27.785 M | -29.250 M |